General Information
DRAVP ID DRAVPe00232
Peptide Name T-20S[138A]
Sequence YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF
Sequence Length 36
UniProt ID No entry found
Source Synthetic construct(derived from Enfuvirtide)
Activity Information
Target Organism HIV
Assay MAGI assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00232
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C202H298N50O63
Absent amino acids CGMPRV
Common amino acids EL
Mass 4434.89
Pl 4.3
Basic residues 3
Acidic residues 7
Hydrophobic residues 14
Net charge -4
Boman Index -6738
Hydrophobicity -80.28
Aliphatic Index 92.22
Half Life
Extinction Coefficient cystines 17990
Absorbance 280nm 514
Polar residues 8
Literature Information
Literature 1
Title Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.
Pubmed ID 19073606
Reference J Biol Chem. 2009 Feb 20;284(8):4914-20.
Author Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.